MUNIQEZZA Trademark

Trademark Overview


On Thursday, November 14, 2019, a trademark application was filed for MUNIQEZZA with the United States Patent and Trademark Office. The USPTO has given the MUNIQEZZA trademark a serial number of 88693000. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 19, 2023. This trademark is owned by Eli Lilly and Company. The MUNIQEZZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anemia, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease
muniqezza

General Information


Serial Number88693000
Word MarkMUNIQEZZA
Filing DateThursday, November 14, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 19, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anemia, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 23, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Tuesday, June 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 19, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 24, 2022SOU EXTENSION 5 GRANTED
Tuesday, October 18, 2022SOU EXTENSION 5 FILED
Tuesday, October 18, 2022TEAS EXTENSION RECEIVED
Tuesday, October 18, 2022TEAS EXTENSION RECEIVED
Friday, April 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 20, 2022SOU EXTENSION 4 GRANTED
Wednesday, April 20, 2022SOU EXTENSION 4 FILED
Wednesday, April 20, 2022TEAS EXTENSION RECEIVED
Thursday, October 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 27, 2021SOU EXTENSION 3 GRANTED
Monday, October 25, 2021SOU EXTENSION 3 FILED
Monday, October 25, 2021TEAS EXTENSION RECEIVED
Saturday, April 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 22, 2021SOU EXTENSION 2 GRANTED
Thursday, April 22, 2021SOU EXTENSION 2 FILED
Thursday, April 22, 2021TEAS EXTENSION RECEIVED
Friday, November 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 5, 2020SOU EXTENSION 1 GRANTED
Tuesday, October 27, 2020SOU EXTENSION 1 FILED
Thursday, November 5, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 27, 2020TEAS EXTENSION RECEIVED
Tuesday, May 19, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 24, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 10, 2020ASSIGNED TO EXAMINER
Saturday, November 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 18, 2019NEW APPLICATION ENTERED